Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) ...

Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...

This Rare Disease Day, observed on Feb. 28 worldwide, the American Kidney Fund is committed to improving the understanding of rare kidney diseases by providing educational resources. An autoimmune ...

"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.

Lifestyle diseases such as high cholesterol, liver disorders, diabetes, and other metabolic conditions are rising rapidly across the world. Swami Ramdev explains how yoga, pranayama, disciplined ...

From football players to military personnel, people who suffer repeated head injuries often face serious long-term health issues. These include problems with memory, mood, and movement, and in some ...

A privacy-first AI can diagnose a life-shortening hormone disorder—just from a photo of your hand.

The family and friends of the teen whose body was found behind a South Wilkes-Barre garage last month have started a petition seeking to “turn tragedy into protection” by creating a ...

Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with ...

Fahima Mustanzid yearns to play a bigger role in finding a health-care solution in the fast-growing city she’s called home ...

Researchers at Kobe University have developed an AI system that can detect acromegaly, a rare hormone disorder, by analyzing photos of the back of the hand and a clenched fist. The disease often ...

Leerink Partners Global Healthcare Conference March 8 - 11, 2026 in Miami, FL Fireside chat on March 9 at 9:20 AM ET InflaRx will also conduct one-on-one investor meetings on March 9th. A link to view ...